Rep. Brian Munroe

Maddy summaryHB 2181 amends Pennsylvania's Controlled Substance Act to define "opioid antagonist" as drugs approved by the U.S. Food and Drug Administration for emergency reversal of opioid overdoses, including naloxone hydrochloride and similar FDA-approved medications. The bill specifically adds these examples to the legal definition within the existing law. This change directly affects healthcare providers, emergency responders, and pharmacists who administer these medications during opioid overdose emergencies by clarifying the legal scope of approved treatments.

Maddy summaryHB 2182 amends Pennsylvania's Controlled Substance Act to allow emergency medical services (EMS) providers to administer opioid overdose medications, specifically naloxone and nalmefene, as part of their standard practice. The bill requires the Department of Health to update EMS provider regulations to include these medications within their scope of practice. This change directly affects EMS personnel by enabling them to respond to opioid overdoses more effectively without needing additional authorization during emergencies. The bill takes effect 60 days after enactment.

Maddy summaryHB 2166 requires cities of the first class in Pennsylvania (like Philadelphia) that collect a nonresident wage tax to remit an amount equal to the tax their home municipality would have collected on that income. This directly affects nonresident workers who live in one municipality but work in a city of the first class, ensuring their home municipality and school district receive the tax revenue they would have earned. The key mechanism mandates a direct transfer of funds to the nonresident's resident municipality and school district, calculated based on the tax the home municipality would impose on earned income and net profits. The bill takes effect 60 days after enactment.

Maddy summaryHB 2158 amends Pennsylvania's Controlled Substance Act by adding specific kratom-related compounds to Schedule I, the most restrictive category for controlled substances. The bill prohibits possession, sale, or distribution of any product containing 7-hydroxymitragynine at 2% or more of total alkaloids, or synthetic versions of kratom alkaloids like mitragynine. This change directly affects businesses selling kratom products and individuals who use such substances, making them illegal without medical authorization. The policy change aligns with existing Schedule I criteria of high abuse potential and no accepted medical use.

Maddy summaryHB 1881 updates Pennsylvania's Pharmacy Act to modernize requirements for pharmacy technicians and trainees, including new registration qualifications and supervision rules by licensed pharmacists. It adds specific protocols for pharmacies administering injectable medications, biologicals (like vaccines), and immunizations, while requiring detailed reports on vaccine administration. The bill also establishes new standards for clinical laboratory certificates and repeals outdated sections of the original 1961 law. These changes directly affect pharmacies, pharmacy technicians, trainees, and pharmacists who oversee vaccine and medication administration.

Maddy summaryHB 2058 would amend Pennsylvania's Controlled Substance, Drug, Device and Cosmetic Act to establish a regulatory framework for kratom. This bill would directly affect businesses selling kratom products and consumers who use it by subjecting kratom to new state regulations. Key provisions would include setting product safety standards, labeling requirements, and distribution rules for kratom under the existing drug regulation system. The bill aims to bring kratom under the state's formal regulatory structure without banning its use.

Maddy summaryHB 1043 amends Pennsylvania's Public School Code to expand access to emergency allergy and asthma treatments in schools. The bill specifically allows school staff, including bus drivers and crossing guards, to possess, use, and administer epinephrine auto-injectors (like EpiPens) and asthma inhalers for students in medical emergencies. It updates definitions and procedures to ensure authorized personnel can act quickly during allergic reactions or asthma attacks without requiring individual physician orders each time. This directly affects students with life-threatening allergies or asthma and school staff who may need to provide immediate care.

Maddy summaryHR 153 designates the week of November 16-22, 2025, as "County Row Office Employee Appreciation Week" in Pennsylvania. This resolution honors county office employees for their service but does not create new laws or provide funding. It is a symbolic gesture with no direct policy changes or financial impact on affected individuals or entities.

Maddy summaryHB 1882 updates Pennsylvania's rules for mortgage lenders and strengthens consumer protections in the mortgage industry. It revises licensing requirements for mortgage loan originators, clarifies exemptions from needing a license, and adds specific safeguards for borrowers. The bill directly affects mortgage lenders operating in Pennsylvania and consumers applying for mortgage loans by changing how lenders must be licensed and what protections must be provided. These changes aim to streamline licensing while ensuring borrowers receive clearer information and fairer treatment during the mortgage process.

Maddy summaryHB 1828 requires health insurance plans in Pennsylvania to cover all recommended vaccines without requiring patients to pay out-of-pocket costs like copays or deductibles. It directly affects insurance companies by mandating this coverage and patients who rely on insurance for routine immunizations (e.g., childhood vaccines, flu shots). The bill adds penalties for insurers that fail to comply with the coverage requirement. This policy change ensures broader access to vaccines by removing financial barriers under insurance plans.